Multiple regulatory elements result in regional specificity in circadian rhythms of neuropeptide expression in mouse SCN

NeuroReport

Volumn 10, Issue 15, 1999, Pages 3165-3174

  Silver, Rae ^a,b,c   Sookhoo, Alicia I ^a   LeSauter, Joseph ^a   Stevens, Paula ^d   Jansen, Heiko T ^d   Lehman, Michael N ^d  

^a Barnard College of Columbia University   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c College of Physicians and Surgeons ^*  (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cholecystokinin; Circadian rhythms; Clock mouse; Suprachiasmatic nucleus; Vasoactive intestinal polypeptide; Vasopressin

Indexed keywords

CHOLECYSTOKININ; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CIRCADIAN RHYTHM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; SUPRACHIASMATIC NUCLEUS;

EID: 0032706349     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199910190-00008     Document Type: Article

References (37)

1. 1. Moore RY and Silver R. Chronobiol Int 15, 475-487 (1998).
2. 2. Vitatema MH, King DP, Chang AM et al. Science 264, 719-725 (1994).
3. 3. King DP, Zhao Y, Sangoram AM et al. Cell 16, 641-653 (1997).
4. 4. Gekakis N, Staknis D, Nguyen HB et al. Science 280, 1564-1569 (1998).
5. 5. Darlington TK, Wager-Smith K. Ceriani MF et al. Science 280, 1599-1603 (1998).
6. 6. Jin X, Shearman LP, Weaver DR et al. Cell 8, 57-68 (1999).
7. 7. Inouye ST, Prog Brain Res 111, 75-90 (1996).
8. 8. Abercrombie M. Anat Rec 94, 239-247 (1946).
9. 9. Castel M, Belenky M, Cohen S et al. Eur J Neurosci. 9, 1950-1960 (1997).
10. 10. Silver R, Romero MT, Besmer HR et al. Neuroreport 7, 1224-1228 (1996)
11. 11. Hartwitch M, Kalsbeek A, Pevet P and Numberger F. Cell Tissue Res 277, 351-361 (1994).
12. 12. Takatsuji K, Miguel-Hidalgo JJ and Tohyama M. Brain Res 568, 223-229 (1991).
13. 13. Card JP and Moore. RY. Neurosci 1, 415-431 (1984).
14. 14. Shearman LP and Weaver DR, Neuroreport 10, 613-618 (1999)
15. 15. Scarbrough K and Turek FW. Brain Res 736, 251-259 (1996).
16. 16. Lucas RJ, Stirland JA, Darrow JM et al. Endocrinology 140, 758-764 (1999).
17. 17. Hara Y, Battey J and Gainer H. Mol Brain Res 8, 319-324 (1990).
18. 18. Carter DA and Murphy D. Mol Brain Res 12, 315-321 (1992).
19. 19. Schade R, Vick K, Ott T et al. Chronobiol Int 12, 87-99 (1995).
20. 20. Della-Fera MA, Koch J, Gingerich RL et al. Physiol Behav 48, 423-428 (1990).
21. 21. Mendelson SC and Quinn JP. Neurosci Lett 184, 125-128 (1995).
22. 22. Otorí Y. Tominaga K, Fukuhara C et al. Brain Res 619, 271-277 (1993).
23. 23. Ban Y, Shigeyoshi Y and Okamura H. J Neurosci 17, 3920-3931 (1997).
24. 24. Speh J and Moore RY. Soc Neurosci Abstr 24, 1918 (1998).
25. 25. Glasgow E, Yamashita M, Kusano K et al. Soc Neurosci Abstr 24, 1852 (1998).
26. 26. Groblewski TA, Nunez AA and Gold RM, Brain Res Bull 6, 125-130 (1981).
27. 27. Boer GJ, van Esseveldt LE and Rietveld WJ. Chronobiol Int 15, 551-566 (1998).
28. 28. Bult A, Hiestand L, Van der Zee EA and Lynch CB. Brain Res Bull 32, 623-627 (1993).
29. 29. Van der Zee EA, Jansen K and Gerkema MP. Brain Res 816, 572-579 (1999).
30. 30. Schroder H, Stehle J and Henschel M. Brain Res 459, 328-332 (1988).
31. 31. Murphy HM, Wideman CH and Nadzam GR. Peptides 17, 467-475 (1996).
32. 32. Brown MH and Nunez AA. Physiol Behav 46, 759-762 (1989).
33. 33. Ingram CD, Snowball RK and Mihai R. Neuroscience 75, 635-641 (1996).
34. 34. Mihai R, Juss TS and Ingram CD. Neurosci Lett 179, 95-99 (1994).
35. 35. Kruisbrink J, Mirmiran M, Van der Woude TP and Boer GJ. Brain Res 419, 76-86 (1987).
36. 36. Arnauld E, Bibene V, Meynard J et al. Am J Physiol 256, R674-R684 (1939).
37. 37 Reghunandanan V, Reghunandanan R, Marya RK and Singh PI. Chronobiol Int 9, 356-361 (1992).